Moreover, recent studies also showed that promoter methylation plays a major role in silencing of the MEG3 gene in pituitary tumor [17], meningiomas [18], cervical cancer [19, 20] and neuroblastoma cell lines [15]. Here, MEG3 is linked to cervical cancer.